Read Feeling Good: The New Mood Therapy Online
Authors: David D. Burns
magnification, 158–59
as maladaptive, 164–94
mind reading, 158
as productive, 163–65
ten things to know about, 194–97
thoughts and, 154–56
Anger Cost-Benefit Analysis,
166
anger hierarchy, 191–93,
192
angry rejection, 303
Anhedonia, 90
antidepressant drug therapy, 10, 11–17, 404, 513n–681
cognitive therapy and, 10–18
antidepressant drugs, xxi, 404, 427, 441, 474–77
augmentation chart,
664–69
augmentation strategy
concerning, 662–71
being treated with, 478
bupropion (Wellbutrin), 605–7
consumer’s guide to, 513n–681
costs of, 515–24
deciding whether or not to take, 479–80
efficiency of, 483
generic, 516
how to tell if working, 484–86
how they work, 443–54
ineffective, 659–71
interactions with other drugs, 505–12
length of time for results concerning, 487
length of time to take, 489–90
MAO inhibitors, 444–48,
514, 520
, 564–98
medical supervision concerning, 480
mirtazapine (Remeron), 615–17
mood elevation and, 486
mood stabilizers,
515, 522
, 617–59
most effective, 483–85
myths concerning, 464–68
names, doses, and costs of,
518–22
preventing or minimizing side effects of, 501–5
reasons for side effects of, 498–501
serotonin antagonists,
514, 521
, 599–605
side effects of, 492–98
simultaneously taking different, 486–87
SSR inhibitors, 449–50,
514, 520
, 547–64
table of,
514–15
taking on long-term basis, 490–91
tapering off, 491
tetracyclic,
514, 519
, 524–27, 534–47
treatment of suicidal patients, 384
tricyclic, 448–49, 501, 514,
518–19
, 524–34, 538–47
venlafaxine (Effexor), 611–15
when not working, 487–89
who benefits from, 480–82
see also
individual names
antiheckler technique, 145
antihistamines, 500
Antiperfectionism Sheet,
357
Antiprocrastination Sheet,
99
antipsychotic medications (neuroleptics), 675–77
Antonuccio, David O., xx, xxi, 463
anxiety disorders, 484
cognitive therapy for, xxii
symptoms of, 26
approval, 290–310
DAS test score and, 285
independence and self-respect, 296–309
need for, 290–92
origin of the problem, 293–96
self, 309–10
Archives of General Psychiatry
, 457
Asendin,
519
side effects, 536
augmentation chart,
664–69
augmentation strategy, 486, 662–71
Authoritative Guide to Self-Help Books
, xxix
autonomy, DAS test score and, 288–89
Aventyl,
517
side effects,
532
averageness, 353
Baxter, Lewis R., Jr., xxi, 457
BDC.
See
Beck Depression Checklist
BDI.
See
Beck Depression Inventory
Beck, Aaron T., 10n, 21n, 51, 53n, 115, 367,383, 413, 420
preface by, xi–xiii
interpreting, 21–27
Beck Depression Inventory (BDI), xxiv, 46, 67, 250, 386, 391
being alone
advantages of, 321
loneliness and, 313–18
benzodiazepines, 671–73
Bergman, Kenneth S., xxii, 457
beta-blockers, 502
bibliotherapy, xxiii–xxix
studies concerning, xxiii–xxix
biological treatments, 460–62
myths concerning, 464–68
vs. psychological treatments, 456–73
studies concerning, 457–60
bipolar (manic-depressive) illness, 428–29, 461–62
symptoms of, 430
boosting self-esteem, 53–80
borderline personality disorder (BPD), 484–85
BPD.
See
borderline personality disorder
brain
biology of, 433–38
research, 453–54
brain chemistry, imbalances in, xxi–xxii, 431–33, 478
theories concerning, 438–43
Brown, Helen Gurley, 334
bupropion (Wellbutrin),
521
, 605–7
doses, 607
drug interactions, 610–11
side effects, 607,
608
Bums Depression Checklist (BDC),
20–21, 22
BuSpar, 450–51
buspirone (BuSpar), 450–51
But-Rebuttal Method, 107–9,
108
Cade, John, 617
Campbell, Barbara D., xxix
“Can’t Lose” System, 124–25,
126
carbamazepine (Tegretol),
522
, 640–41
blood testing, 641–43
doses, 641
drug interactions, 646–51,
648–50
side effects, 643–46
Celexa,
520
Center for Cognitive Therapy, 13, 22n
chemotherapy, 233
citalopram (Celexa),
520
Cleveland Clinic, 463
clomipramine (Anafranil), 484,
518
side effects,
530
coercion, 92, 116–17
cognitive distortions, 201, 238–39, 393, 402–3
definitions of, 32–41,
42–43
of suicidal individuals, 392, 394, 401
cognitive rehearsal, 191, 194
cognitive therapy, xvii–xxiiin, 57
anger and, 153
antidepressant drug therapy and, 13–14
for anxiety disorders, xxii
for depression, 13–18,
15
dialogue between client and therapist, 410–11
for eating disorders, xxiii
effectiveness of, xx
helplessness and, 419–20
hostility and, 411–16
ingratitude and, 416–17
mood-control techniques of, 10–11
origin of, 9–10
for personality disorders, xxii
principles of, 12–13
self-criticism vs. self-defense, 62–68, 69, 76–77, 134, 244, 261
studies concerning, xx–xxxi, 18
for suicidal individuals, 383–84, 393–99, 401–3
theory of, xvii–xix
uncertainty and, 419–22
compulsive slowness, 359–60
cooling hot thoughts, 167–69
coping, 70–78
with criticism, 144
with helplessness, 419–22
with hostility, 411–16
with ingratitude, 416–17
with uncertainty, 419–23
Cosmopolitan
, 334
criticism
coping with, 146
fear of, 92
overcoming fear of, 131–44
Daily Activity Schedule, 94–98, 95
Daily Record of Dysfunctional Thoughts, 65–67,
66
, 100–4,
101–3
, 106–7,
170
, 208
Danton, William G., 463
DAS.
See
Dysfunctional Attitude Scale
death wish, 386–87
defeating guilt, 205–28
antiwhiner technique, 22
Daily Record of Dysfunctional Thoughts, 208
developing perspective, 225–26
learning to stick to your guns, 218–22
Moorey moaner method, 223–25
“should” removal techniques, 208–18
DeNelsky, Gurland Y., xx, 463
Depakene,
522
Depakote,
522
dependency, 311
need for love and, 311, 312–15, 324–26
depression, xx, xxx–xxxi
antidepressant drug therapy and, 13–18
antiheckler technique, 145
BDC scores, evaluating, 24–25
the Beck Depression Inventory (BDI), xxiv, 46, 67, 250, 386, 391
brain chemistry imbalance and, xxi–xxii
cognitive therapy as treatment for, 12–18
drugs as treatment for, xx–xxi
effects of, 28
environmental influences role in, 428–31
Freud on, 144
genetic influences role in, 428–31, 460–62
hopelessness and, 387, 405–6
identifying silent assumptions downward-arrow method, 264–88
medical science’s approach to, 403–4
mild chronic, 24
National Institute of Mental Health on, 16–17
negative self-evaluation, 54–56
negative thinking and, 28–29, 47–48, 58–59
physical symptoms of, 25–26, 432
prevalency of, 9
as product of mental slippage, 13
psychotherapy for, xxi–xxii
realistic, 233
relapses, xxvii–xxviii, 492
sadness and, 231–32
schizophrenia and, 57–58
self-dislike and, 53
sexual drive and, 58
suicide and, 383
willpower and, 81
see also antidepressant drug therapy; suicidal individual
Depression: Causes and Treatment
(Beck), 53, 383n
Depression: Clinical, Experimental & Theoretical Aspects
(Beck), 53n
Descartes, René, 455
desipramine (Norpramin, Pertofrane),
518
side effects,
531
Desyrel, 451–52, 484,
521
, 599
doses, 600
drug interactions, 603–5
side effects, 600–3, 601
Diagnostic and Statistical Manual (DSM
), xxvi
disapproval, 301–9
fear of, 290–92
self-respect and, 301–9
disarming critics, 137–42
disarming technique, 117–19
disattribution, 225–26
disqualifying the positive, 34–36, 42
divalproex sodium (Depakote),
522
do-nothingism, 81–130
coercion, 92
examples of, 83
fear of disapproval or criticism, 92
fear of failure, 90–91
fear of success, 91–92
guilt, 93
hopelessness, 82
jumping to conclusions, 89
low frustration tolerance, 92–93
overwhelming oneself, 89
perfectionism, 90
resentment, 92
self-activation methods, 94–130
self-blame, 93
self-labeling, 89–90
undervaluing the rewards, 90
doxepin (Adapin, Sinequan), 484,
518
side effects,
531
DSM.
See Diagnostic and Statistical Manual
Dunton, William G., xx
Dyer, Wayne, 162–63
Dysfunctional Attitude Scale (DAS), 270–89, 296
interpreting your score, 285–89
scoring, 281–84
Dysfunctional Thoughts, Daily Record of, 65–67,
66
, 100–4,
101–3
, 106–7,
170
, 208
dysthymic disorder, 24
eating disorders, cognitive therapy for, xxiii